Maravai Lifesciences Holdings Inc. (MRVI)
NASDAQ · Healthcare
Maravai Lifesciences Holdings Inc. Long Term Debt 2020–2025
Maravai Lifesciences Holdings Inc. annual long term debt history from 2020 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Maravai Lifesciences Holdings Inc. long term debt as of December 31, 2025: 350.5M, a 3.44% decrease year-over-year.
- Maravai Lifesciences Holdings Inc. long term debt for 2025 were 350.5M, a 3.44% decrease from 2024.
- Maravai Lifesciences Holdings Inc. long term debt for 2024 were 363.0M, a 39.31% decrease from 2023.
- Maravai Lifesciences Holdings Inc. long term debt for 2023 were 598.1M, a 4.28% increase from 2022.
- Maravai Lifesciences Holdings Inc. long term debt for 2022 were 573.6M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Maravai Lifesciences Holdings Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $351 |
| 2024 | $363 |
| 2023 | $598 |
| 2022 | $574 |
| 2021 | $565 |
| 2020 | $585 |
Maravai Lifesciences Holdings Inc. Long Term Debt — FAQ
Maravai Lifesciences Holdings Inc. (MRVI) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRVI's long term debt history?
The chart and table above show Maravai Lifesciences Holdings Inc.'s long term debt by year and by quarter, including the growth rate.